Specific Treatment-outcome association studies of COVID-19

When:  Dec 1, 2020 from 9:00 AM to 10:00 AM (ET)
Moderators: Ann McMahon and Montse Soriano-Gabarro
  • Clinical Outcomes From COVID-19 Following Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers Among Patients with Hypertension in South Korea: A nationwide study.
  • Ju Hwan Kim, Sungkyunkwan University, Suwon, Korea, Republic of
  • Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
  • Lars Christian Lund, University of Southern Denmark, Odense, Denmark
  • Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study.
  • Sascha Dublin, Kaiser Permanente Washington Health Research Institute, Seattle, USA, Department of Epidemiology, University of Washington, Seattle, USA
  • Inhaled corticosteroid use and risk of COVID-19 related death among 967,047 patients with COPD or asthma: an OpenSAFELY analysis
  • Anna Schultze, London School of Hygiene and Tropical Medicine, London, United Kingdom